Trim GS 25-30% to Underweight; honor 8/18 binding meta-rule as eight consecutive decisions produced zero/negative alpha
Underweight rating is an analytical capital allocation call, not a thesis-invalidation call. The structural case remains compelling (17% ROE vs 12-14% peer average, $25B annualized buybacks representing 8.5% of market cap, 200 SMA at $929 as structural floor), but the binding meta-rule from the 8/18 reflection mandates Underweight after eight consecutive zero-or-negative alpha decisions. The 25-30% trim preserves the structural thesis while acknowledging that the rangebound alpha-drag pattern must be actively terminated. Full exit would be value-destroying and would violate the cross-ticker lesson about preserving calls without donating alpha. The 30-day clock ensures the decision framework remains disciplined—if neither stop fires and no re-engagement trigger executes, formal coverage reduction to Hold or Sell follows.
| Position | Action |
|---|---|
| Current levels ($1,015-$1,025) | Trim 25-30% of GS exposure over 1-2 sessions |
| Hard stop at $980.75 with >2.5M volume | Exit remaining 75% core position (thesis invalidation) |
| Close below $928.96 (200 SMA) | Full position exit (structural thesis invalidation) |
| $998.79 (BOLL lower) defended with RSI sub-40 and MACD histogram compressing toward zero | Scale into 1/3 position size |
| Sustained reclaim of $1,053 (50 SMA) with >2.5M shares and positive MACD histogram cross | Add to full size |
| 30-day clock expires with neither stop firing and no re-engagement trigger executed | Formal coverage reduction to Hold or Sell |
Buy GS into the $1,000–$1,020 zone targeting $1,098 near-term and $1,152 on the next leg, with stop below $980.75 — the confirmation is in the fundamentals, not the technicals.
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 44.59 | neutral |
| MACD | -4.18 | bearish |
| MACD Signal | -3.53 | bearish |
| MACD Histogram | -0.65 | bearish |
| ATR(14) | $28.99 | neutral |
| 10 EMA | $1,037.83 | bearish |
| 50 SMA | $1,053.22 | bearish |
| 200 SMA | $928.96 | bullish |
| Bollinger Upper | $1,076.79 | neutral |
| Bollinger Lower | $998.79 | neutral |
| Volume | 2,648,970 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Then: Scale into 1/3 position size
Goldman's AWM acquisitions are deliberately re-mixing revenue toward capital-light recurring-fee income, creating a BlackRock-style multiple re-rating opportunity.
EV: +$1,098 near-term (R2 target), $1,152 on next leg (52-week high); asymmetric risk/reward favors bulls decisively with worst-case ~4% downside vs significant upside · concedes: Near-term technical weakness acknowledged: stock below 10 EMA, below 50 SMA, MACD negative, RSI at 44, lower highs, distribution day volume of 2.65M; 10 EMA failing as resistance is real; The 3-week basing pattern the bull承认 could resolve either way; Bear's discipline in waiting for confirmation is understandable, though characterized as potential 'paralysis'
Goldman Sachs trades at peak-cycle multiples (13.8x forward PE) on earnings built from the lowest cycle base, while technicals show a distribution pattern with lower highs, sustained negative momentum, and a cycle-top buyback trap—the risk asymmetry is not in bulls' favor at current prices.
· concedes: Long-term structural trend is intact: stock at $1,021 with rising 200 SMA at $929 is in a primary uptrend; 12-month rally from $695 to $1,152 is real; Fundamentals, ROE leadership, and buyback program are real; 50 SMA reclaim at $1,053 would be a valid re-entry trigger (+3% upside)
→ vs conservative: Applying 1:1 risk-reward logic to a stock that is structurally a coiled spring with 17% ROE, 8.5% annual buyback support, and a structural 200 SMA that is rising, not falling
→ vs conservative: Waiting for MACD histogram confirmation before adding exposure means missing the first 5% of the next leg up chasing validation that only comes after the move has begun
→ vs conservative: Trading a chart instead of a business when the business is extraordinary with record earnings and strategic AWM pivot toward recurring revenue
→ vs neutral: Lower-highs pattern and bearish momentum divergence ignore ATR contraction from $39 to $29, volume profile of institutional profit-taking vs. panic liquidation, and rising 200 SMA structural support
→ vs neutral: Symmetrical 1:1 risk-reward snapshot ignores the asymmetrical structural setup driven by 8.5% buyback support, 17% ROE, and reopening capital markets cycle over a 3-6 month horizon
→ vs neutral: Being neutral on GS in this macro setup—8% recession probability, stable NIM, Treasury steepening, energy M&A hot—is fighting the tape, not respecting it
| Daily Change | -$18.82 (-1.81%) | bearish |
Support: 1014.5 · 998.79 · 980.75 · 928.96 | Resistance: 1152.07 · 1098 · 1053.22 · 1037.83
GS exhibits a classic late-stage bull correction: long-term trend remains bullish (close +10% above 200 SMA), but medium- and short-term trends are bearish (below 50 SMA and 10 EMA). Momentum is deteriorating with RSI recycling in the 45-52 range and MACD negative since late July. A bearish momentum divergence exists (lower highs in both price and RSI versus early July peak). Key levels to watch: resistance at $1,053 (50 SMA) and $1,037.83 (10 EMA); support at $998.79 (lower Bollinger) and $980.75 (Jul 29 low). Recommendation: HOLD with bearish tilt for traders; HOLD/accumulate near $1,000 for long-term investors.
Market Capitalization
$297.48B
PE Ratio (TTM)
15.79x
Forward PE
13.80x
PEG Ratio
1.48
Price-to-Book
2.79x
EPS (TTM)
$64.72
Forward EPS
$74.03
Dividend Yield
1.92%
Beta
1.288
52-Week High
$1,153.99
52-Week Low
$705.55
50-Day Moving Average
$1,053.69
200-Day Moving Average
$932.87
Book Value per Share
$366.45
Revenue (TTM)
$67.57B
Net Income (TTM)
$19.98B
Profit Margin
31.04%
Operating Margin
42.18%
Return on Equity (ROE)
16.90%
Return on Assets (ROA)
1.07%
Current Ratio
1.563
Q2 2026 Revenue
$17.23B
Q2 2026 Diluted EPS
$20.98
Q1 2026 Net Income
$5.63B
2025 Revenue
$58.28B
2025 Net Income
$17.18B
2025 Diluted EPS
$51.32
2024 Revenue
$53.51B
2024 Net Income
$14.28B
2023 Revenue
$46.25B
2023 Net Income
$8.52B
2022 Revenue
$47.37B
2022 Net Income
$11.26B
2025 Compensation Expense
$19.62B
2025 Other Non-Interest Expense
$12.62B
Total Assets (Q1 2026)
$2,060.2B
Total Liabilities (Q1 2026)
$1,937.4B
Total Equity (Q1 2026)
$122.78B
Common Equity (Q1 2026)
$109.08B
Preferred Stock (Q1 2026)
$13.70B
Tangible Book Value (Q1 2026)
$101.56B
Total Debt (Q1 2026)
$434.74B
Cash & Equivalents (Q1 2026)
$179.53B
Net Loans (Q1 2026)
$252.85B
Trading Securities (Q1 2026)
$512.66B
2025 Operating Cash Flow
-$45.15B
2025 CapEx
-$2.06B
2025 Free Cash Flow
-$47.22B
2025 Dividends Paid
$5.28B
2025 Buybacks
$12.36B
Q1 2026 Buybacks
$6.45B
Diluted Shares Outstanding (Q2 2026)
305M
Diluted Shares Outstanding (2022)
358M
Treasury Stock (Q1 2026)
$125.9B
Net Interest Income 2025
$13.56B
Net Interest Income 2024
$8.06B
Net Interest Income 2023
$6.35B
Q1 2026 Net Interest Income
$3.55B
Debt-to-Equity (reported)
725x
Strengths
Concerns
Goldman Sachs is a mega-cap investment bank and financial services firm ($297.48B market cap) operating across Global Investment Banking, Global Markets, and Asset & Wealth Management segments. The company reported record Q2 2026 results with $17.23B revenue and $20.98 EPS (+92% YoY), demonstrating powerful cyclical recovery from 2023's trough. With 16.90% ROE, 31.04% net margin, and aggressive buybacks returning ~$25B+ annually, GS is in excellent fundamental condition—though the stock trades near 52-week highs at 15.79x trailing PE with elevated 1.29 beta, limiting margin of safety in a cyclical business.
Macro: Hawkish FOMC hold with 86% implied probability of no rate cuts in 2026; US recession risk at 8% (soft landing priced); Treasury expanding long-bond buybacks (curve steepening); Strait of Hormuz closed with oil ~$92 (+36%); S&P 500 near records with AI sector leadership.